MedTrace Logo

Changes in Cytokine Levels During an Acute Exacerbation of Chronic Obstructive Pulmonary Disease

NCT00281242 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2016-01-29

No results posted yet for this study

Summary

The purpose of this study is to determine whether there is a statistical association between changes in sputum serial levels of two cytokines, interleukin (IL)-17 and IL-6, during the treatment course of a severe acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) and during the clinical course itself (i.e., rate of recovery or potential complicated course). AE-COPD is defined as an episode requiring emergency room (ER) evaluation.

Conditions

  • Pulmonary Disease, Chronic Obstructive
  • Lung Diseases, Obstructive

Interventions

OTHER

blood draw

All subjects undergo blood draws at study visits and at the time of COPD exacerbation visits.

Sponsors & Collaborators

Principal Investigators

  • Jeffrey L. Curtis · University of Michigan at Ann Arbor

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2010-06-30
Completion
2010-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00281242 on ClinicalTrials.gov